Medication reconciliation enhances the accuracy of gastric emptying scintigraphy.
Gastric emptying scintigraphy
Gastroparesis
Medication reconciliation
Patient safety
Radiopharmacy
Journal
EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628
Informations de publication
Date de publication:
26 Sep 2024
26 Sep 2024
Historique:
received:
09
07
2024
accepted:
18
09
2024
medline:
26
9
2024
pubmed:
26
9
2024
entrez:
26
9
2024
Statut:
epublish
Résumé
Gastroparesis (GP) is a prevalent sensorimotor disorder characterized by delayed gastric emptying without mechanical obstruction, posing significant diagnostic challenges. Gastric emptying scintigraphy (GES) is the gold standard for diagnosing GP. However, its accuracy can be compromised by many medications that affect gastric motility. This study evaluates the impact of medication reconciliation on the diagnostic accuracy of GES. A significant proportion of patients (75%) were on medications known to affect gastric motility. Recommendations for medication adjustments were communicated, with 30% non-adherence. Adjustments in GES interpretations were necessary for 20% of patients following comprehensive medication reviews. The involvement of radiopharmacists facilitated accurate diagnostic conclusions, underscoring the critical role of medication reconciliation in GES accuracy. Medication reconciliation enhanced the accuracy of GES in diagnosing gastroparesis, emphasizing the need to integrate clinical pharmacy practices into nuclear medicine. This interdisciplinary approach not only improves diagnostic accuracy but also enhances patient safety, advocating for the adoption of such practices in the management of gastroparesis.
Sections du résumé
BACKGROUND
BACKGROUND
Gastroparesis (GP) is a prevalent sensorimotor disorder characterized by delayed gastric emptying without mechanical obstruction, posing significant diagnostic challenges. Gastric emptying scintigraphy (GES) is the gold standard for diagnosing GP. However, its accuracy can be compromised by many medications that affect gastric motility. This study evaluates the impact of medication reconciliation on the diagnostic accuracy of GES.
RESULTS
RESULTS
A significant proportion of patients (75%) were on medications known to affect gastric motility. Recommendations for medication adjustments were communicated, with 30% non-adherence. Adjustments in GES interpretations were necessary for 20% of patients following comprehensive medication reviews. The involvement of radiopharmacists facilitated accurate diagnostic conclusions, underscoring the critical role of medication reconciliation in GES accuracy.
CONCLUSION
CONCLUSIONS
Medication reconciliation enhanced the accuracy of GES in diagnosing gastroparesis, emphasizing the need to integrate clinical pharmacy practices into nuclear medicine. This interdisciplinary approach not only improves diagnostic accuracy but also enhances patient safety, advocating for the adoption of such practices in the management of gastroparesis.
Identifiants
pubmed: 39325280
doi: 10.1186/s41181-024-00299-3
pii: 10.1186/s41181-024-00299-3
doi:
Types de publication
Journal Article
Langues
eng
Pagination
68Informations de copyright
© 2024. The Author(s).
Références
Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753–63.
doi: 10.1111/j.1572-0241.2007.01636.x
pubmed: 18028513
Anandabaskar N. Drugs Affecting Gastrointestinal Motility. In: Paul A, Anandabaskar N, Mathaiyan J, Raj GM, editors. Introduction to Basics of Pharmacology and Toxicology: Volume 2: Essentials of Systemic Pharmacology : From Principles to Practice [Internet]. Singapore: Springer Nature; 2021 [cited 2023 Mar 17]. pp. 569–79. https://doi.org/10.1007/978-981-33-6009-9_35
Banks KP, Syed K, Parekh M, McWhorter N. Gastric Emptying Scan. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2023 Mar 17]. http://www.ncbi.nlm.nih.gov/books/NBK531503/
Camilleri M, Kuo B, Nguyen L, Vaughn VM, Petrey J, Greer K, et al. ACG Clinical Guideline: Gastroparesis. Off J Am Coll Gastroenterol ACG. 2022;117(8):1197.
doi: 10.14309/ajg.0000000000001874
D’hulster E, Quintens C, Bisschops R, Willems R, Peetermans WE, Verbakel JY, et al. Cost-effectiveness of check of medication appropriateness: methodological approach. Int J Clin Pharm. 2022;44(2):399–408.
doi: 10.1007/s11096-021-01356-6
pubmed: 35013878
Dilmaghani S, Zheng T, Camilleri M. Epidemiology and Healthcare Utilization in patients with gastroparesis: a systematic review. Clin Gastroenterol Hepatol off Clin Pract J Am Gastroenterol Assoc. 2023;21(9):2239–e22512.
DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol off J Div Health Psychol Am Psychol Assoc. 2004;23(2):207–18.
Garrigue P, Bodin-Hullin A, Gonzalez S, Sala Q, Guillet B. An alternate, Egg-Free Radiolabeled Meal Formulation for Gastric-Emptying Scintigraphy. Clin Nucl Med. 2017;42(7):540–1.
doi: 10.1097/RLU.0000000000001658
pubmed: 28394838
Hasler WL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol. 2011;8(8):438–53.
doi: 10.1038/nrgastro.2011.116
pubmed: 21769117
Implementation of ward. -based clinical pharmacy services in Belgium–description of the impact on a geriatric unit. - PubMed - NCBI. [cited 2018 Sep 7]. https://www.ncbi.nlm.nih.gov/pubmed/16569792
Jalleh RJ, Jones KL, Rayner CK, Marathe CS, Wu T, Horowitz M. Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control. Diabetologia. 2022;65(12):1981–93.
doi: 10.1007/s00125-022-05796-1
pubmed: 36194250
pmcid: 9630190
Johnson B, Herman A, Paulsen A, Myhrvold R. 99mTc-Sulfur Colloid Egg Preparation. J Nucl Med. 2020;61(supplement 1):3056–3056.
Lacy BE, Wise JL, Cangemi DJ. Gastroparesis: time for a paradigm change. Curr Opin Gastroenterol. 2023;39(6):503.
doi: 10.1097/MOG.0000000000000978
pubmed: 37678168
Lattard C, Baudouin A, Larbre V, Herledan C, Cerutti A, Cerfon MA et al. Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review. J Cancer Res Clin Oncol. 2023.
Maurer AH. Advancing gastric emptying studies: standardization and New parameters to assess gastric motility and function. Semin Nucl Med. 2012;42(2):101–12.
doi: 10.1053/j.semnuclmed.2011.10.001
pubmed: 22293165
Meher BR, Agrawal K, Gnanasegaran G. Review of adverse reactions Associated with the Use of Common Diagnostic Radiopharmaceuticals. Indian J Nucl Med IJNM off J Soc Nucl Med India. 2021;36(2):163–7.
doi: 10.4103/ijnm.ijnm_219_20
Miller TA. Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis. Patient Educ Couns. 2016;99(7):1079–86.
doi: 10.1016/j.pec.2016.01.020
pubmed: 26899632
pmcid: 4912447
Nail V, Moyon A, Nachar O, Gabriel S, Guillet B, Garrigue P. Pharmaceutical interviews to overcome digestive artefacts on [99mTc]Tc-tetrofosmin myocardial perfusion scintigraphy. J Clin Pharm Ther. 2021;46(5):1480–3.
doi: 10.1111/jcpt.13418
pubmed: 33754343
Pascal P, Couturier O, Ruggeri V, Baillet C, Salaun PY, Cassol E, et al. Guide pour la réalisation d’un examen de scintigraphie de vidange gastrique. Médecine Nucl. 2022;46(2):100–11.
doi: 10.1016/j.mednuc.2022.01.126
Patel J, Bhatt S. Clinical pharmacist in Nuclear Medicine: a New Role in Ascendancy. Indian J Pharm Pract. 2014;7(3):14–8.
doi: 10.5530/ijopp.7.3.4
Recommandations de bonnes pratiques. – bonnes pratiques de pharmacie clinique. Pharm Clin. 2022;57(2):108–24.
Shin AS, Camilleri M. Diagnostic Assessment of Diabetic Gastroparesis. Diabetes. 2013;62(8):2667–73.
doi: 10.2337/db12-1706
pubmed: 23881199
pmcid: 3717858
Tutar MS, Sekmenli N, Erol G, Karaarslan E, Yildiz M, Kozanhan B. Does the menstrual phase affect gastric emptying? Prospective, observational study. Eur Rev Med Pharmacol Sci. 2023;27(5):1989–95.
pubmed: 36930497
Weber MM. Trust the Gold Standard: all glucagon-like Peptide-1 receptor agonists can Delay Gastric Emptying. Anesthesiology. 2024;140(1):178–80.
doi: 10.1097/ALN.0000000000004752
pubmed: 37934577
Wise JL, Vazquez-Roque MI, McKinney CJ, Zickella MA, Crowell MD, Lacy BE. Gastric emptying scans: poor adherence to National guidelines. Dig Dis Sci. 2021;66(9):2897–906.
doi: 10.1007/s10620-020-06314-2
pubmed: 32418002
Ye Y, Jiang B, Manne S, Moses PL, Almansa C, Bennett D, et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut. 2021;70(4):644–53.
doi: 10.1136/gutjnl-2020-321277
pubmed: 32493829
Ye Y, Yin Y, Huh SY, Almansa C, Bennett D, Camilleri M. Epidemiology, etiology, and treatment of gastroparesis: real-world evidence from a large US National Claims Database. Gastroenterology. 2022;162(1):109–e1215.
doi: 10.1053/j.gastro.2021.09.064
pubmed: 34624355